| Hepatocellular Carcinoma |
1 |
1 |
| Cancer |
0 |
0.85 |
| Biologic Therapy |
0 |
0.81 |
| Lung Cancer |
0 |
0.57 |
| Liver |
0 |
0.53 |
| Bladder Cancer |
0 |
0.51 |
| Toxicology |
0 |
0.44 |
| Liver Failure |
0 |
0.43 |
| Liver Disease |
0 |
0.41 |
| Immunotherapy |
0 |
1 |
| Hemorrhage |
0 |
0.21 |
| Diarrhea |
0 |
0.13 |
| Pain Management |
0 |
0.13 |
| Abdominal Pain |
0 |
0.12 |
| Acute Kidney Injury |
0 |
0.11 |
| Hepatitis |
0 |
0.11 |
| Hepatitis A |
0 |
0.11 |
| Intracranial Hemorrhage |
0 |
0.11 |
| Pain |
0 |
0.11 |
| Thromboembolism |
0 |
0.1 |
| Traumatic Brain Injury |
0 |
0.1 |
| Portal Vein Thrombosis |
0 |
0.09 |
| Renal Failure |
0 |
0.09 |
| VEGF Inhibitor |
0 |
0.07 |
| Abdomen |
0 |
0.05 |
| Anemia |
0 |
0.05 |
| Angiogenesis Inhibitors |
0 |
0.05 |
| Attending Physician |
0 |
0.05 |
| Biliary Tract |
0 |
0.05 |
| Bladder |
0 |
0.05 |
| California |
0 |
0.05 |
| Cardiac Arrest |
0 |
0.05 |
| Colitis |
0 |
0.05 |
| Fatigue |
0 |
0.05 |
| Humanized Monoclonal Antibody |
0 |
0.05 |
| Inflammatory Bowel Disease |
0 |
0.05 |
| Injury |
0 |
0.05 |
| Kidney |
0 |
0.05 |
| Lung |
0 |
0.05 |
| New York |
0 |
0.05 |
| Pneumonia |
0 |
0.05 |
| Pruritus |
0 |
0.05 |
| Sepsis |
0 |
0.05 |
| Thrombosis |
0 |
0.05 |
| Tumor |
0 |
0.05 |
| Vascular Endothelial Growth Factor |
0 |
0.05 |
| Vein |
0 |
0.05 |
| Wound Management |
0 |
0.05 |